ClinicalTrials.gg
Not yet recruitingNCT07909980Updated Nov 2, 2026

Impact Of Aerobic Exercise on Sleep Quality and Postural Control Interplay Among University Students

An interventional study of Aerobic exercise Training and Sleep hygiene education in Healthy Individuals, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the impact of moderate-intensity aerobic treadmill exercise on sleep quality and postural control interplay among university students with poor sleep quality. Sleep disturbances are highly prevalent in university populations and can lead to impaired balance and increased postural sway. While aerobic exercise is known to enhance sleep quality, its combined effect on objective postural control measures remains understudied in this group.

Sixty-six university students (aged 18-25 years) with self-reported poor sleep quality will be randomly allocated into two equal groups: an intervention group (aerobic exercise training plus sleep hygiene education) and a control group (sleep hygiene education only). Primary and secondary outcomes include sleep quality, objective balance indices, dynamic balance, insomnia severity, anxiety levels, and mindfulness assessed pre- and post-intervention at 6 weeks.

Read the detailed description

This study investigates the reciprocal relationship and interplay between sleep quality and postural control among young adults, evaluating how a structured moderate-intensity aerobic exercise intervention impacts both primary outcomes. Participants meeting the eligibility criteria are randomized into two parallel groups: an experimental group receiving a 6-week treadmill exercise intervention combined with sleep hygiene education, and a control group receiving sleep hygiene education alone.

The exercise program consists of treadmill walking/jogging performed 3 sessions per week for 6 consecutive weeks. Each session lasts 40 minutes and comprises a 5-minute low-speed warm-up, 30 minutes of continuous moderate-intensity exercise calibrated to 60-75% of maximum heart rate (HRmax), and a 5-minute cool-down. Exercise heart rates are continuously monitored to ensure adherence to target intensity ranges. The standardized sleep hygiene education includes advice on regular sleep schedules, optimal sleep environment, and restriction of stimulant intake before sleep. Baseline and post-intervention evaluations assess sleep architecture, postural stability metrics, day-time sleepiness, anxiety levels, and sleepiness-related mindfulness to determine the potential therapeutic synergistic effects of aerobic exercise on the sleep-balance relationship.

02

Conditions studied

  • Healthy Individuals

Keywords

  • Sleep Quality
  • Aerobic Exercise
  • Postural Control
  • Balance
  • Sleep Disorders
  • University Student
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 66 is close to the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both male and female university students aged 18-25 years.
  • Low level of physical activity as defined by the International Physical Activity Questionnaire (IPAQ).
  • Poor sleep quality as defined by a Pittsburgh Sleep Quality Index (PSQI) score > 5.
  • Able to perform aerobic exercise safely, as confirmed by a health screening questionnaire.
  • Willingness to participate and provide written .

Exclusion criteria

Exclusion Criteria:

  • History of vestibular, neurological, or musculoskeletal disorders affecting balance.
  • Cardiovascular or respiratory conditions limiting aerobic exercise performance.
  • Recent musculoskeletal or neurological lower limb injury within the last 6 months.
  • Current use of sleep medications or participation in another structured exercise program.
  • Currently diagnosed with moderate to severe sleep disorder.
  • Participation in a structured exercise program within the past 3 months.
  • Current substance abuse.
  • History of brain injury or visual impairment that affects balance.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    Control Group (n = 33)

    33 participants in this group will receive sleep Hygiene Education Only • Standardized sleep hygiene education session (15-30 mins). • Weekly adherence checklist monitoring while maintaining usual daily activities.

    Behavioral: Sleep hygiene education

  • Experimental
    Intervention Group (n = 33)

    Aerobic exercise training on treadmill (3 sessions/week for 6 weeks) combined with sleep hygiene education

    Behavioral: Aerobic exercise Training · Behavioral: Sleep hygiene education

Interventions

  • BehavioralAerobic exercise Training

    Participants in intervention group will undertake a 6-week moderate-intensity aerobic exercise program performed on a motorized treadmill for 3 sessions per week. Each session lasts 40 minutes, consisting of a 5-minute warm-up (low-speed walking), 30 minutes of continuous walking/jogging at 60-75% of maximum heart rate (HRmax), and a 5-minute cool-down.

  • BehavioralSleep hygiene education

    A standardized sleep hygiene education program consisting of a 15-30 minute instructional session (verbal explanation and printed brochure) covering healthy sleep practices and environment adjustments. Participants will maintain their usual daily activities for 6 weeks with weekly compliance monitoring.

06

What researchers measure

Primary outcomes

  1. Sleep Quality (PSQI Global Score)

    Pittsburgh Sleep Quality Index (PSQI) Global Score (scale range: 0 to 21, where lower scores indicate better sleep quality).

    Time frame: Baseline (Pre-intervention) and Post-intervention (Week 6)

Secondary outcomes

  1. Overall Stability Index (OSI)

    Overall Stability Index (OSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater postural instability and worse outcome)

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

  2. Insomnia Severity Index (ISI)

    Assesses the nature, severity, and impact of insomnia symptoms over the past two weeks using a 7-item self-report questionnaire, with total scores ranging from 0 to 28 (where higher scores indicate greater insomnia severity and worse outcome).

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

  3. Generalized Anxiety Symptoms (GAD-7)

    Measures the severity of generalized anxiety symptoms over the past two weeks using a 7-item scale, with total scores ranging from 0 to 21 (where higher scores indicate greater anxiety severity and worse outcome).

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

  4. Mindfulness Attention Awareness Scale (MAAS)

    Measures the general tendency to be attentive to and aware of present-moment experiences in daily life using the 15-item Mindful Attention Awareness Scale, with total scores ranging from 15 to 105 (where higher scores indicate greater mindfulness and better outcome).

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

  5. Anterior-Posterior Stability Index (APSI)

    Anterior-Posterior Stability Index (APSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater instability and worse outcome

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

  6. Medial-Lateral Stability Index (MLSI)

    Medial-Lateral Stability Index (MLSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater instability and worse outcome)

    Time frame: Baseline (pre-intervention) and post-intervention (at 6 weeks)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 1,207 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 2 months is below that.

Counting every sponsor, half of 1,285 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2026
First posted
Nov 2, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07909980
Lead sponsor
Cairo University
Collaborators
October University for Modern Sciences and Arts
Responsible party
Waad Atef Ahmed Atia (Teaching assistant, Cairo University) — Principal investigator
First posted
Nov 2, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Nov 2, 2026

Study contacts

Waad Atef Ahmed Atia, Bachelor's degree
Contact
waatia@msa.edu.eg
+201094924064
Ebtesam Nabil Abdelmohsen, Assistant Professor
principal investigator · Cairo University
Mohamad Abdelfatah Sakr, Associate Professor of Neurolo
principal investigator · Faculty of Medicine, Misr University for Science and Technology
Sandra Aziz Guirguis, Lecturer
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion